Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 20,700 shares at $486.36 ($10.0M) on 2025-12-11, disclosed to the SEC on 2025-12-12.
Scheduled sale ($10.0M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $482.22 | 560 | $270K | 2.7% |
| 2 | $482.22 | 560 | $270K | 2.7% |
| 3 | $483.25 | 900 | $435K | 4.3% |
| 4 | $484.31 | 5,220 | $2.5M | 25.2% |
| 5 | $484.31 | 5,220 | $2.5M | 25.2% |
| 6 | $485.22 | 2,804 |
| $1.4M |
| 13.6% |
| 7 | $485.22 | 2,804 | $1.4M | 13.6% |
| 8 | $486.36 | 1,116 | $543K | 5.4% |
| 9 | $486.36 | 1,116 | $543K | 5.4% |
| 10 | $487.37 | 400 | $195K | 1.9% |
| Total | $484.68 avg | 20,700 | $10.0M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |